AI in Healthcare: Ethical Challenges & Solutions

Artificial intelligence (AI) and machine learning (ML) has gained a significant position in every field, especially health sector bringing significant transformation in the field of functional foods and nutraceuticals. The research and development departments, historically, were dependent on typical and traditional methodologies, now extended using AI-driven strategies to enhance the formulation of supplements. By using AI, nutraceutical industry can increase the development of synergistic herbal supplements, forecast the techniques of nanotechnology and able to provide personalized supplements according to individual health profile.

Artificial intelligence can facilitate researchers quickly examining the statistics including extensive datasheets, and revealing patterns & insights, therefore enhancing and improving the development of efficient and targeted nutraceutical solutions. The inclusion of technology in nutritional science improves product effectiveness facilitating a new age of precision health treatments.

AI in Nutraceutical Development

AI models like DeepChem and AlphaFold have transformed phytochemical screening by accurately and swiftly predicting their bioavailability, stability, and medicinal potential. AlphaFold Server by Google DeepMind is the most precise tool globally for predicting protein interactions with other molecules within the cell. It is a complimentary platform accessible to scientists globally for non-commercial research purposes. Biologists may utilize AlphaFold 3 to simulate structures of proteins, DNA, RNA, and various ligands, ions, and chemical changes with minimal effort. This feature is especially advantageous in tackling issues such as the inadequate solubility of curcumin, withaferin A. and other bioactive substances recognized for their multifunctional health characteristics. The AI-assisted design of nano-carriers, such as liposomes and polymeric nanoparticles, has shown around 300 to 500% enhancement in curcumin absorption, hence improving its therapeutic efficacy. These advancements underscore AI's ability to optimize the dissemination and effectiveness of nutraceutical substances.

Providing personalized nutrition or diet plan according to individual’s health profile is a difficult task for all the dietitians sitting in the hospitals. Artificial intelligence has come up with personalization of nutrition by customizing diet plans according to individual health and genetic profile, metabolic responses and gut microbiome composition. ZOE is an online organization working by employing artificial intelligence and assessing patients at home and delivering individualized dietary advice and nutritional guidance. It examines gut microbiota intended to enhance gut and overall health and wellbeing. Zoe is based on a comprehensive study which demonstrates that every individual exhibit different response to the same meals, highlighting the need for tailored dietary treatments. The use of AI to interpret complex biological data allows for personalized nutrition programs to deliver more effective and individualized health interventions.

Machine learning algorithms are optimizing the formulation and production processes of nutraceuticals. Platforms like Google's Vertex AI allow the modelling of various formulation factors, including pH, temperature, and excipient interactions, to determine the best stable and bioavailable product compositions. Furthermore, AI-driven systems such as Brightseed's Forager® are expediting the identification of bioactive chemicals in flora. Forager® analyses extensive datasets to identify novel bioactives and their health advantages, therefore greatly minimizing the time and resources needed for research and development. These technical breakthroughs are boosting product development efficiency and extending the possibility for novel nutraceutical solutions.

Challenges and Ethical Considerations

Artificial intelligence (AI) is revolutionizing healthcare by facilitating advancements in diagnosis, therapy optimization, and patient care. However, its integration presents ethical, regulatory, and social concerns. Primary concerns encompass data privacy vulnerabilities, algorithmic prejudice, and regulatory deficiencies that fail to keep up with improvements in artificial intelligence. The use of personal health data requires rigorous privacy safeguards to avoid unauthorized access and exploitation. Algorithmic bias can compromise the tenets of fairness, justice, and equity in healthcare, perpetuating systematic prejudice and diminishing faith in the healthcare system, highlighting the necessity for varied and representative training datasets. To alleviate bias in AI and ML algorithms, coordinated efforts are necessary across several domains, including data acquisition, algorithm formulation, and model assessment.

Healthcare organizations must prioritize the variety and representativeness of training data, ensuring that datasets inclusively reflect varied patient groups and consider demographic, socioeconomic, and cultural variables. This may entail proactively sourcing and integrating data from marginalized groups, utilizing data augmentation methods to rectify disparities, and partnering with varied stakeholders to guarantee the inclusion of data gathering initiatives. Regulatory agencies such as the FDA and EFSA are endeavoring to modify current frameworks to integrate AI-generated supplements. Guaranteeing the safety and efficacy of AI-driven nutraceuticals need rigorous clinical validation and transparent approaches. Ethical issues, including as informed consent and the equitable allocation of AI advantages, must be addressed to cultivate public trust and acceptance.

Conclusion

The incorporation of AI into healthcare offers significant prospects and substantial obligations. Although AI improves diagnosis accuracy, therapeutic effectiveness, and patient accessibility, its ethical, regulatory, and social problems necessitate meticulous oversight. Utilizing AI in bioactive screening, personalized nutrition, and optimized manufacturing enables the sector to provide more effective and customized health solutions to customers. Nonetheless, actualizing this promise necessitates confronting ethical and legal difficulties to guarantee responsible AI implementation. The healthcare industry can fully utilize AI and ML technology to usher in a new age of individualized, data-driven healthcare that puts patient well-being and equity first by adopting ethical best practices and encouraging cooperation between interdisciplinary teams. As researchers and industry stakeholders traverse this dynamic terrain, it will be essential to harness AI's transformational potential while maintaining ethical standards to influence the future of nutraceuticals.

Please note that the views expressed in this article are of the author and do not necessarily reflect the views or policies of any organization.

The writers are affiliated with 1 National Institute of Food Science and Technology, University of Agriculture, Faisalabad, and 2 Institute of Food Science & Nutrition, University of Sargodha, Sargodha, Pakistan. For correspondence, please contact * Mian Kamran Sharif at mks@uaf.edu.pk

Related Stories